ARTG 260239Clinical chemistry biological screening IVDs
ARTG ID: 260239 · Abbott Rapid Diagnostics Pty Ltd · Abbott Diagnostics Korea Inc · Class IIa · Started September 23, 2015
Good Name: Abbott Rapid Diagnostics Pty Ltd T/A Alere - Clinical chemistry biological screening IVDs
- Risk Class
- Class IIa
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 260239
- Start Date
- September 23, 2015
- Effective Date
- September 11, 2020
- Country
- South Korea
- Address
- 65 Borahagal-ro Giheung-gu Yongin-si Gyeonggi-do, Korea, 17099
IVDs intended for the qualitative and/or quantitative screening of urine for chemical, cellular and/or other components.
Access comprehensive regulatory information for Clinical chemistry biological screening IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 260239 and sponsored by Abbott Rapid Diagnostics Pty Ltd, manufactured by Abbott Diagnostics Korea Inc in South Korea. The device registration started on September 23, 2015.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.